Table 5 Association between TMEFF1 expression and pathological features in ovarian cancer
From: ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
Features | Cases | High expression cases | High expression rate% | P-value |
|---|---|---|---|---|
FIGO stage | Â | Â | Â | 0.001*** |
I-II | 35 | 15 | 47.7 | |
III-IV | 56 | 43 | 77.0 | |
Differentiation | Â | Â | Â | 0.575 |
Well-moderate | 44 | 30 | 68.1 | |
Poorly | 47 | 28 | 59.6 | |
LNmetastasis | Â | Â | Â | 0.001*** |
No | 40 | 18 | 45.0 | |
Yes | 28 | 24 | 85.7 | |
no lymphadenectomy | 23 | 16 | 69.6 | |
Pathologic type | Â | Â | Â | >0.05 |
Serous | 38 | 25 | 65.8 | |
Mucinous | 11 | 7 | 63.6 | |
Endometrioid | 18 | 10 | 55.5 | |
Clear cell carcinoma | 8 | 5 | 62.5 | |
Poorly differentiated adenocarcinoma | 16 | 11 | 68.8 | |
Notes: ***P < 0.01 |  | |||